Patent Assignment
Reel/Frame 048712/0691
Assignment of Assignor's Interest
Recorded: 2019-03-27
Pages: 7
Assignor
MACLAREN, ANN
Executed: 2019-03-21
Assignee
TRIPHASE ACCELERATOR U.S. CORPORATION
3366 N. TORREY PINES CT., #210, LA JOLLA, CALIFORNIA, 92307
Covered Properties
(2)
Anti-CD22 Antibody-Maytansine Conjugates, Combinations,and Methods of Use Thereof
PCT:
PCT/US2018/064879 ↗
Anti-CD22 Antibody-Maytansine Conjugates, Combinations, and Methods of Use Thereof
Application:
16/216,233 →
Publication:
US 2019/0201541
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 16, 2021
From: TRIPHASE ACCELERATOR U.S. CORPORATION
To: TRIPHASE RESEARCH AND DEVELOPMENT III CORP.
Reel/Frame 055944/0177 →
Assignment of Assignor's Interest
May 23, 2023
From: TRIPHASE RESEARCH AND DEVELOPMENT III CORP.
To: R.P. SCHERER TECHNOLOGIES, LLC
Reel/Frame 063740/0236 →
Assignment of Assignor's Interest
Jul 10, 2023
From: TRIPHASE RESEARCH AND DEVELOPMENT III CORP.
To: R.P. SCHERER TECHNOLOGIES, LLC
Reel/Frame 064197/0253 →
Security Interest
Dec 19, 2024
From: CATALENT CTS (KANSAS CITY), LLC; REDWOOD BIOSCIENCE, INC.; R.P. SCHERER TECHNOLOGIES, LLC; CATALENT WELLNESS, LLC
To: ARES CAPITAL CORPORATION, AS COLLATERAL AGENT
Reel/Frame 069743/0458 →